India Respiratory Care Devices Market Report 2026-2034: Reaching USD 1,762.7 Million at 7.69% CAGR

How Is the India Respiratory Care Devices Market Performing?

The India respiratory care devices market is experiencing steady and sustained growth, driven by the rising burden of respiratory disorders, an aging population, and continuous technological advancements in diagnostic and therapeutic solutions. Healthcare providers and patients alike are increasingly adopting portable, non-invasive, and AI-enabled respiratory devices that improve treatment accessibility and patient outcomes across both urban and rural settings.

Increased government investment in healthcare infrastructure, growing awareness of chronic respiratory conditions, and surging demand for home-based care solutions are further accelerating adoption. The market was valued at USD 887.1 Million in 2025 and is projected to reach USD 1,762.7 Million by 2034, growing at a CAGR of 7.69% during 2026-2034.

Growth is being driven by an expanding geriatric population, worsening air pollution, rising prevalence of COPD, asthma, and sleep apnea, alongside rapid integration of IoT-enabled monitoring systems and AI-powered diagnostic tools. As respiratory health becomes a national healthcare priority, India is emerging as one of Asia's most dynamic and fast-growing respiratory care device markets.

Market Snapshot

• Market Size (2025): USD 887.1 Million
• Forecast Value (2034): USD 1,762.7 Million
• CAGR (2026-2034): 7.69%
• Leading Segment by Product Type: Therapeutic Devices
• Leading Segment by Indication: Chronic Obstructive Pulmonary Disease (COPD)
• Leading Segment by End User: Hospitals and Clinics

Evaluate Market Opportunity with the Business Sample Report: https://www.imarcgroup.com/india-respiratory-care-devices-market/requestsample

What Growth Factors Are Driving the India Respiratory Care Devices Market?

• Rising Prevalence of Chronic Respiratory Disorders:

India bears one of the world's highest burdens of chronic respiratory conditions, including COPD, asthma, and obstructive sleep apnea - collectively affecting hundreds of millions of individuals. Air pollution from vehicular emissions, industrial activity, crop burning, and indoor biomass combustion is significantly exacerbating the incidence and severity of these conditions across both urban and rural populations. This sustained disease burden is generating consistent, long-term demand for therapeutic devices, diagnostic equipment, and monitoring solutions that support both acute hospital care and ongoing home-based disease management.

• Expanding Geriatric Population Increasing Respiratory Care Demand:

India's elderly population is set to soar from 153 million individuals aged 60 and above to an estimated 347 million by 2050, according to UNFPA data, representing a profound demographic shift with direct implications for healthcare demand. Aging individuals face significantly elevated risk for COPD, sleep apnea, and acute respiratory infections, requiring advanced support solutions including oxygen concentrators, ventilators, and CPAP devices. Healthcare providers are responding by expanding home-based respiratory care programs, while government initiatives to strengthen geriatric health infrastructure are reinforcing investment in accessible and affordable respiratory technologies.

• Technological Innovation in Portable and Non-Invasive Devices:

Continuous innovation in device miniaturization, connectivity, and clinical functionality is expanding the addressable patient population for respiratory care solutions. Portable oxygen concentrators, next-generation non-invasive ventilators, and smart inhalers are transforming care delivery by enabling effective treatment outside of traditional hospital settings. In December 2024, Cipla launched CipAir - a mobile application using acoustic analysis and AI to assess asthma risk - exemplifying how digital health innovation is extending respiratory care management to individual patients through accessible, consumer-grade interfaces.

• Integration of AI and IoT in Respiratory Monitoring Systems:

The convergence of artificial intelligence and Internet of Things connectivity is enabling real-time, continuous respiratory health monitoring that moves care from episodic clinical visits to persistent, data-driven management. AI-driven algorithms analyze patient-generated data to detect deterioration patterns, optimize treatment protocols, and trigger timely clinical interventions - reducing hospitalizations and improving long-term outcomes. IoT-enabled devices transmitting respiratory metrics to cloud platforms allow clinicians to remotely monitor high-risk patients, supporting the government's broader push for digital health ecosystem development across India.

• Growing Healthcare Investment and Infrastructure Expansion:

India's sustained increase in public and private healthcare expenditure is strengthening the supply chain, clinical infrastructure, and distribution networks necessary for respiratory care device adoption at scale. Rising health insurance penetration, expanding diagnostic center networks, and government programs targeting communicable and non-communicable disease burden are collectively improving patient access to respiratory diagnostics and treatment. International medtech companies are accelerating India market entry - as demonstrated by Aerogen's March 2025 Delhi headquarters launch - reflecting confidence in India's long-term healthcare growth trajectory.

What Are the Latest Emerging Trends in the India Respiratory Care Devices Market?

• AI-Powered Diagnostic and Screening Applications:

Mobile and cloud-based AI tools are democratizing respiratory screening by enabling risk assessment outside formal clinical settings. Applications leveraging acoustic analysis, machine learning, and patient-reported symptom data are identifying at-risk individuals earlier, improving referral pathways, and reducing diagnostic delays for conditions like asthma and COPD. As smartphone penetration deepens across India's semi-urban and rural populations, AI-driven respiratory screening is expected to become a significant component of preventive healthcare strategies.

• Shift Toward Home-Based and Ambulatory Respiratory Care:

Growing patient preference for managing chronic conditions at home - combined with healthcare system pressure to reduce hospital occupancy - is accelerating demand for compact, user-friendly respiratory devices designed for non-clinical environments. Oxygen concentrators, portable nebulizers, and CPAP devices suited for home use are seeing rising adoption, supported by telemedicine platforms that connect patients with respiratory specialists remotely. This shift is creating new distribution and service model opportunities for device manufacturers and healthcare providers.

• Launch of Advanced Ventilation Solutions for ICU and Pediatric Settings:

Global medtech companies are introducing next-generation ventilators in India that combine affordability with clinical sophistication, targeting both adult and pediatric patient populations. Getinge's February 2024 launch of the Servo-c ventilator in India - featuring CO2 monitoring and modular components designed for accessibility - illustrates the trend toward purpose-built solutions that address India's specific clinical and affordability requirements, strengthening ICU capabilities across hospital networks.

• Expansion of Medtech Companies into Tier II and Tier III Cities:

As metropolitan markets mature, respiratory care device manufacturers are increasingly targeting smaller cities and district hospitals with accessible, cost-optimized product lines. Localized distribution partnerships, government tender participation, and community health program integration are extending device reach into previously underserved populations - broadening the overall addressable market while addressing public health priorities around respiratory disease burden reduction.

• Growth of Aerosol Drug Delivery and Combination Therapy Platforms:

Innovation in aerosol drug delivery systems is creating new clinical applications at the intersection of pharmaceutical and device markets. Advanced nebulizer and inhaler platforms are improving drug deposition efficiency, reducing dosage requirements, and enhancing patient adherence - particularly for pediatric and geriatric patients who face challenges with conventional inhaler technique. Aerogen's India expansion specifically targeting COPD management underscores the commercial opportunity in specialized aerosol delivery technology across the country's large chronic respiratory patient population.

What Opportunities Lie Ahead for the India Respiratory Care Devices Market in the Coming Years?

The India respiratory care devices market presents compelling growth opportunities through 2034, supported by a large and growing patient population, rising healthcare awareness, increasing insurance penetration, and accelerating integration of digital health technologies into clinical and home care pathways. The convergence of AI-driven diagnostics, IoT-enabled remote monitoring, and next-generation therapeutic devices is creating a technology ecosystem that delivers measurably improved patient outcomes while expanding the commercial addressable market.

Companies that invest in affordable portable device platforms, AI-powered home monitoring solutions, aerosol drug delivery systems, and geographically diversified distribution networks are well-positioned to outperform as competition intensifies. Government-led healthcare infrastructure programs, expanding geriatric care requirements, and rising post-infectious respiratory disease burden - including long-term sequelae from respiratory infections - represent sustained demand drivers through the forecast period.

How Is the India Respiratory Care Devices Market Segmented?

By Product Type:

• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Indication:

• Chronic Obstructive Pulmonary Disease - COPD
• Infectious Diseases
• Asthma
• Sleep Apnea
• Others

By End User:

• Hospitals and Clinics
• Ambulatory Care Centers
• Others

By Region:

• South India
• North India
• East India
• West India

Competitive Landscape

The report offers an in-depth examination of the competitive landscape, including market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Detailed profiles of all major companies operating in the India respiratory care devices market have also been provided.

Investment & Growth Opportunities

• Portable oxygen concentrators and home-use CPAP/BiPAP devices for India's expanding home respiratory care segment

• AI-powered mobile screening and diagnostic applications targeting asthma and COPD detection in underserved populations

• IoT-enabled remote patient monitoring platforms for chronic respiratory disease management across distributed care networks

• Advanced aerosol drug delivery and smart inhaler systems for pediatric and geriatric patient populations

• Affordable, ICU-grade ventilators and non-invasive ventilation solutions for Tier II and Tier III hospital markets

• Ambulatory and community health-oriented respiratory diagnostic devices aligned with government preventive healthcare programs

Request Customized Data Tailored to Your Interest: https://www.imarcgroup.com/request?type=report&id=31175&flag=E

India Respiratory Care Devices Market Recent Developments & News

• March 2025: Aerogen, an Ireland-based medtech company, opened its India headquarters in Delhi to expand respiratory care access for over 55 million COPD patients. Inaugurated by Minister James Lawless, the facility focuses on advancing aerosol drug delivery solutions and strengthening healthcare collaboration across the region.

• December 2024: Cipla launched CipAir, a free Android-based mobile application for asthma screening in India, using acoustic analysis and AI to assess asthma risk and guide users toward appropriate clinical actions - enhancing patient empowerment in respiratory self-management.

• February 2024: Getinge launched its advanced Servo-c ventilator in India, designed for both pediatric and adult patients with features including CO2 monitoring and modular components, strengthening ICU respiratory care capabilities and reinforcing the company's commitment to affordable healthcare innovation in the country.

• Ongoing: Rising air pollution across India's major urban corridors and Indo-Gangetic Plain continues to elevate incidence of COPD, asthma, and other chronic respiratory conditions, sustaining long-term demand for both diagnostic and therapeutic device solutions.

• Ongoing: Government initiatives focused on geriatric healthcare and non-communicable disease management are driving sustained public and private investment in respiratory care infrastructure across primary, secondary, and tertiary health settings.

Frequently Asked Questions

How big is the India respiratory care devices market?
➤ The India respiratory care devices market size was valued at USD 887.1 Million in 2025.

What is the future outlook of the India respiratory care devices market?
➤ The market is expected to grow at a CAGR of 7.69% from 2026 to 2034, reaching USD 1,762.7 Million by 2034, driven by rising respiratory disease prevalence, aging demographics, AI-powered device innovation, and expanding home-based care adoption.

What are the key factors driving the India respiratory care devices market?
➤ Key drivers include the rising burden of COPD, asthma, and sleep apnea; an expanding geriatric population; integration of AI and IoT in respiratory monitoring; growing healthcare investment; and increasing demand for portable, non-invasive home care devices.

Which segment dominates the India respiratory care devices market by product type?
➤ Therapeutic Devices lead the market, encompassing oxygen concentrators, ventilators, nebulizers, and CPAP/BiPAP systems.

Which indication leads the market?
➤ Chronic Obstructive Pulmonary Disease (COPD) leads, reflecting India's large and growing patient population affected by pollution, tobacco use, and occupational exposure.

Which end user segment leads the India respiratory care devices market?
➤ Hospitals and Clinics lead as the primary procurement and utilization channel for advanced respiratory care devices.

Which region leads the India respiratory care devices market?
➤ South India leads, supported by advanced hospital infrastructure, higher health insurance penetration, and a strong medtech manufacturing ecosystem across Bengaluru, Chennai, and Hyderabad.

Get Samples of Our Latest In-Depth Reports On Related Topics:

✤ India Ambulance Services Market: https://www.imarcgroup.com/india-ambulance-services-market/requestsample

✤ India Oxygen Concentrator Market: https://www.imarcgroup.com/india-oxygen-concentrator-market/requestsample

✤ India Active Pharmaceutical Ingredients Market: https://www.imarcgroup.com/india-active-pharmaceutical-ingredients-market/requestsample

✤ India Wearable Medical Devices Market: https://www.imarcgroup.com/india-wearable-medical-devices-market/requestsample

✤ India Pacemaker Market: https://www.imarcgroup.com/india-pacemaker-market/requestsample

IMARC Group is a global management consulting firm that helps ambitious changemakers create a lasting impact. The company offers comprehensive market assessment, feasibility studies, incorporation support, regulatory assistance, branding and strategy services, and procurement research.

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel: (D) +91 120 433 0800
United States: +1-201971-6302

This release was published on openPR.